Abeona Therapeutics Inc. Common Stock (ABEO) — Analysis Summary
Abeona Therapeutics Inc. Common Stock (ABEO) has a market cap of $329.43M with year-over-year revenue growth of +66.3%. Net margin stands at 1223.1%. The stock trades at a P/E ratio of 5.0.
Key Takeaways
- Revenue changed +66.3% year-over-year
- Net margin of 1223.1%
- P/E ratio of 5.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ABEO posted revenue growth of +66.3% and trades at a P/E of 5.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.